metricas
covid
Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Prognostic factors after resection of colorectal cancer liver metastases
Información de la revista
Vol. 85. Núm. 1.
Páginas 32-39 (enero 2009)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 85. Núm. 1.
Páginas 32-39 (enero 2009)
Acceso a texto completo
Prognostic factors after resection of colorectal cancer liver metastases
Factores pronósticos tras resección hepática de metástasis hepáticas de cáncer colorrectal
Visitas
1142
Caridad Marín Hernández, Ricardo Robles Campos
Autor para correspondencia
rirocam@um.es

Author for correspondence.
, Domingo Pérez Flores, Asunción López Conesa, Pascual Parrilla Paricio
Unidad de Cirugía Hepática y Trasplante Hepático, Departamento de Cirugía, Hospital Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Abstract
Introduction

There are many studies that analyse preoperative factors with a poor prognosis in patients undergoing surgery for colorectal carcinoma liver metastases, in order to avoid unnecessary surgery. However, there are few studies that evaluate the intra-and postoperative prognostic factors. The aim of this study is to analyse pre-, intra-, and postoperative prognostic factors in a series of 210 patients undergoing surgery for colorectal carcinoma liver metastases, with special emphasis on the postoperative factors that can give us information on the aggressiveness of the tumour and the curative effectiveness of the surgery.

Patients and method

Between September 1996 and December 2006, 210 patients undergoing surgery for colorectal carcinoma liver metastases in whom we analysed pre-, intra-, and postoperative factors of survival. Mean follow-up was 55 (3) months (range, 12–124 months).

Results

The postoperative mortality rate was 1.4% and the morbidity rate was 22%. Actuarial and disease-free survival at 1-, 3-, and 5-years was 89.9% versus 63%, 66.9% versus 32%, and 53.8% vs 23%, respectively. Among the preoperative factors analysed, the age >65 years and LM size >5cm were independent predictors of poor overall survival, whereas the other 2 significant factors were obtained from those analysed postoperatively: presence of microsatellitosis and postoperative CEA levels (at 1 and 3 months).

Conclusions

In patients with colorectal carcinoma liver metastases we must take into account certain postoperative factors that can give us information on the aggressiveness of the tumour and the effectiveness of the surgery.

Keywords:
Liver resection
Prognostic factors
Liver colorectal metastases
Carcinoembryonic antigen
Resumen
Introducción

Numerosos estudios han analizado los factores de mal pronóstico preoperatorios en pacientes sometidos a resección hepática por metástasis hepáticas de cáncer colorrectal (MHCCR) con el fin de seleccionar a los pacientes para tratamiento quirúrgico. Sin embargo, los factores intraoperatorios y postoperatorios han sido poco analizados. El objetivo de este estudio es determinar los factores preoperatorios, intraoperatorios y postoperatorios en una serie de 210 pacientes intervenidos por MHCCR, con especial énfasis en los factores postoperatorios, que podrían informar acerca de la agresividad del tumor y de la eficacia curativa de la cirugía realizada.

Pacientes y método

Realizamos un estudio prospectivo en 210 pacientes intervenidos de MHCCR entre septiembre de 1996 y diciembre de 2006, en el que analizamos factores de supervivencia preoperatorios, intraoperatorios y postoperatorios. El seguimiento fue de 55±3 (intervalo, 12–124) meses.

Resultados

La mortalidad postoperatoria fue del 1,4% y la morbilidad, del 22%. Las supervivencias actuariales frente a intervalos libres de enfermedad a 1, 3 y 5 años fueron del 89,9 frente al 63%, el 66,9 frente al 32% y el 53,8 frente al 23%, respectivamente. Entre los factores preoperatorios analizados, la edad > 65 años y el tamaño de la metástasis >5cm fueron factores de mal pronóstico independientes, mientras que dos factores significativos de mal pronóstico fueron obtenidos del análisis postoperatorio: microsatelitosis y cifras postoperatorias de CEA >5ng/ml (a 1 y 3 meses).

Conclusiones

En pacientes con MHCCR es necesario tener en cuenta los factores postoperatorios que pueden informarnos acerca de la agresividad del tumor y de la eficacia de la cirugía.

Palabras clave:
Resección hepática
Factores pronósticos
Metástasis hepáticas colorrectales
Antígeno carcinoembrionario
El Texto completo está disponible en PDF
References
[1.]
B. Cady, M.D. Stone.
The role of surgical resection of liver metastases in colorectal carcinoma.
Semin Oncol, 8 (1991), pp. 399-406
[2.]
M. Choti, J. Sitzman, M. Tiburi, F. Marcelo, R. Rangsin, R. Schulick, et al.
Trends in long-term survival following liver resection for hepatic colorectal metastases.
Ann Surg, 235 (2002), pp. 759-766
[3.]
R.L. Andújar, E.M. Orón, A.M. Herráiz, C.R. Cano, F.S. Rodríguez, E.P. Ibars, et al.
Reflexiones sobre 250 intervenciones por metástasis hepáticas de cáncer colorrectal.
Cir Esp, 81 (2007), pp. 269-275
[4.]
Y. Fong, J. Fortner, R.E. Sun, M.F. Brennan, E.H. Blumgart.
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.
Ann Surg, 230 (1999), pp. 309-318
[5.]
B. Nordlinger, M. Guiguet, J.C. Vaillant, P. Balladur, K. Boudjema, P. Bachellier, et al.
Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients.
Cancer, 77 (1996), pp. 1254-1262
[6.]
S. Iwatsuki, I. Dvorchik, J.R. Madariaga, J.W. Marsh, F. Dodson, A.C. Bonham, et al.
Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system.
J Am Coll Surg, 189 (1999), pp. 291-299
[7.]
M. Minagawa, M. Makuuchi, G. Torzilli, T. Takayama, S. Kawasaki, T. Kosuge, et al.
Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results.
Ann Surg, 231 (2000), pp. 487-499
[8.]
T.J. Gayowski, S. Iwatsuki, J.R. Madariaga, R. Selby, S. Todo, W. Irish, et al.
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors.
Surgery, 116 (1994), pp. 703-710
[9.]
M. Taylor, J. Foster, B. Langer, B.R. Taylor, P.D. Greig, C. Mahut.
A study of prognostic factors for hepatic resection for colorectal metastases.
Am J Surg, 173 (1997), pp. 467-471
[10.]
K. Shirabe, K. Takenaka, T. Gion, Y. Fujiwara, M. Shimada, K. Yanaga, et al.
Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin.
Br J Surg, 84 (1997), pp. 1077-1080
[11.]
A. Sasaki, S. Kai, Y. Endo, K. Iwaki, H. Uchida, M. Tominaga, et al.
Prognostic value of preoperative peripheral blood monocyte count in patients with colorectal liver metastases after liver resection.
J Gastrointest Surg, 11 (2007), pp. 596-602
[12.]
M.D. Morales, R. Robles, C. Marín, A. Capel, V. Vázquez, M. Reus, et al.
Cálculo del volumen hepático mediante TC espiral: utilidad en la planificación de la resección hepática mayor en pacientes no cirróticos.
Cir Esp, 76 (2004), pp. 152-158
[13.]
R. Robles, C. Marín, B. Abellán, A. López, P. Pastor, P. Parrilla.
A new approach to hand-assisted laparoscopic liver surgery.
[14.]
R. Robles, C. Marín, B. Abellán, A. López, P. Ramírez, P. Parrilla.
Hepatectomía izquierda y derecha realizadas mediante abordaje laparoscópico asistido con la mano. Descripción de una técnica original.
Cir Esp, 80 (2006), pp. 326-330
[15.]
C. Laurent, A. Sa Cunha, E. Rullier, D. Smith, J. Saric.
Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastases.
J Am Coll Surg, 198 (2004), pp. 884-891
[16.]
K.J. Halazun, A. Aldoori, H.Z. Malick, A. Al-Mukhtar, K.R. Prasad, G.J. Togood, et al.
Elevated preoperative neutrophil to limphocyteratio predicts survival following hepatic resection for colorectal liver metastases.
Eur J Surg Oncol, 34 (2007), pp. 55-60
[17.]
D. Jaeck, H. Nakano, P. Bachellier, K. Inoue, J.C. Weber, E. Oussoultzoglou, et al.
Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study.
Ann Surg Oncol, 9 (2002), pp. 430-438
[18.]
H. Wanebo, Q. Chu, M. Vezeredis, C. Soderberg.
Patient selection for hepatic resection of colorectal metastases.
Arch Surg, 13 (1996), pp. 322-329
[19.]
N. Chafai, C.L.H. Chan, E.L. Bokey, O.F. Dent, G. Sinclair, P.H. Chapuis.
What factors influence survival in patients with unresected synchronous liver metastases after resection of colorectal cancer?.
Colorectal Dis, 7 (2005), pp. 176-181
[20.]
R. Adam, V. Delvart, G. Pascal, A. Valeanu, D. Castaing, D. Azoulay, et al.
Rescue surgery for unresectable colorectal cancer liver metastases downstaged by chemoterapy: a model to predict long-term survival.
Ann Surg, 240 (2004), pp. 644-658
[21.]
N. Yoshiyuki, N. Mitsuo, K. Sahio, K. Hiromichi, H. Michiyoshi, A. Yukio, et al.
Clinical predictors of recurrence site after hepatectomy for metastasic colorectal cancer.
Hepato-Gastroenterology, 48 (2001), pp. 1680-1684
[22.]
D. Elias, L. Sideris, M. Pocard, J.F. Oullet, V. Boige, P. Lasser, et al.
Results of R0 resection for colorectal liver metastases asociated with extrahepatic disease.
Ann Surg, 11 (2004), pp. 274-280
[23.]
H. Ueno, H. Mochizuki, Y. Hashiguchi, K. Hatsuse, H. Fujimoto, K. Hase.
Predictors of extrahepatic recurrence after resection of colorectal liver metastases.
Br J Surg, 91 (2004), pp. 327-333
[24.]
R. Adam, G. Pascal, D. Azoulay, K. Tanaka, D. Castaing, H. Bismuth.
Liver resection for colorectal metastases: the third hepatectomy.
[25.]
J. Scheele, R. Stang, A. Altendorf-Hofman, M. Paul.
Resection of colorectal liver metastases.
World J Surg, 19 (1995), pp. 59-71
[26.]
K.S. Hughes, R.B. Rosenstein, S. Songhorabodi, M.A. Adson, D.M. Ilstrup, J.G. Fortner, et al.
Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survival.
Colorectal Dis, 31 (1988), pp. 1-4
[27.]
K. Shirabe, K. Takenaka, T. Gion, Y. Fujiwara, M. Shimada, K. Yanaga, et al.
Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin.
Br J Surg, 84 (1997), pp. 1077-1080
[28.]
B. Cady, R. Jenkins, G. Steele, W. Lewis, M. Stone, W. McDermott, et al.
Surgical margin in hepatic resection for colorectal metastases: a critical and improvable determinant of outcome.
Ann Surg, 227 (1998), pp. 566-571
[29.]
N. Kokudo, Y. Miki, S. Sugai, A. Yanagisawa, Y. Kato, Y. Sakamoto, et al.
Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection.
Arch Surg, 137 (2002), pp. 833-840
[30.]
J. Yamamoto, K. Sugihara, T. Kosuge, T. Takayama, K. Shimada, S. Yamasaki, et al.
Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer.
Ann Surg, 221 (1995), pp. 74-78
[31.]
J. Figueras, J. Torras, J. Martí-Rague, C. Valls, E. Ramos, M. Navarro, et al.
Resección quirúrgica de las metástasis hepáticas de carcinoma colorrectal. Tratamiento de las recidivas.
Cir Esp, 76 (2004), pp. 292-299
[32.]
R. Adam, G. Pascal, D. Castaing, D. Azoulay, V. Delvart, B. Paule, et al.
Tumour progression while on chemotherapy: a contraindication to the liver resection for multiple colorectal metastases?.
Ann Surg, 240 (2004), pp. 1052-1064
[33.]
G. Mentha, P.E. Majno, A. Andres, L. Rubbia-Brandt, P. Morel, A.D. Roth.
Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary.
Br J Surg, 93 (2006), pp. 872-878
[34.]
G. Marín-Hargreaves, V. Artigas, J.A. González, C. Martínez, E. Marcuello, M. Trías-Folch.
Cirugía secuencial inversa después de quimioterapia neoadyuvante por metástasis hepáticas sincrónicas de cáncer colorrectal.
Cir Esp, 82 (2007), pp. 235-237
[35.]
H.J. Wanebo, B. Rao, C.M. Pinsky, R.G. Hoffman, M. Stearns, M.K. Schwartz, et al.
The use of preoperative carcynoembryonic antigen level as a prognostic indicator to complement pathological staging.
N Engl J Med, 299 (1978), pp. 448-451
[36.]
H. Ueno, H. Mochizuki, K. Hatsuse, K. Hase, T. Yamamoto.
Indicators for treatment strategies of colorectal liver metastases.
Ann Surg, 231 (2000), pp. 59-66
[37.]
P. Hohenberger, P.M. Schlag, T. Gerneth, C. Herfarth.
Pre and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariante analysis.
Ann Surg, 219 (1994), pp. 135-143
[38.]
P. Gervaz, A. Blanchard, S. Pampallona, J.P. Mach, C. Fontolliet, M. Gillet, et al.
Prognostic value of postoperative carcinoembryonic antigen concentration and extent of invasion of resection margins after hepatic resection for colorectal metastases.
Eur J Surg, 166 (2000), pp. 557-561
Copyright © 2009. Asociación Española de Cirujanos
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos